4//SEC Filing
Klencke Barbara 4
Accession 0000899243-23-015639
CIK 0001783328other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:13 PM ET
Size
5.5 KB
Accession
0000899243-23-015639
Insider Transaction Report
Form 4
Klencke Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+36,524→ 36,524 totalExercise: $2.66Exp: 2033-06-12→ Voting Common Stock (36,524 underlying)
Footnotes (1)
- [F1]35,000 shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2024 and (ii) the next annual meeting of the Issuer's stockholders, with 1,524 shares subject to this option vesting and becoming exercisable in full on June 13, 2023, in each case subject to the Reporting Person's continued service at such time.
Documents
Issuer
TScan Therapeutics, Inc.
CIK 0001783328
Entity typeother
Related Parties
1- filerCIK 0001647647
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:13 PM ET
- Size
- 5.5 KB